823 SERUM HUMAN GLANDULAR KALLIKREIN 2 (HK2) AND PRO-HK2 CONCENTRATION CHANGES COMPARED TO PROSTATE SPECIFIC ANTIGEN IN PATIENTS UNDERGOING PRIMARY RADIOTHERAPY OR BRACHYTHERAPY

Risk assessment for biochemical recurren

Risk assessment for biochemical recurrence prior to radical prostatectomy: Significant enhancement contributed by human glandular kallikrein 2 (hK2) and free prostate specific antigen (PSA) in men with moderate PSA-elevation in serum

✍ Thomas Steuber; Andrew J. Vickers; Alexander Haese; Charlotte Becker; Kim Petter 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 French ⚖ 122 KB

## Abstract Most models to predict biochemical recurrence (BCR) of prostate cancer use pretreatment serum prostate‐specific antigen (PSA), clinical stage and prostate biopsy Gleason grade. We investigated whether human glandular kallikrein 2 (hK2) and free prostate‐specific antigen (fPSA) measured